# Naheed Kurji

> Naheed Kurji is a seed investor in Toronto backing Biotechnology and Medical. See 2 investments, round sizes, portfolio and contact details. Updated Oct 2026.

- Type: Angel Investor
- Location: Toronto, Canada
- Total investments: 2
- Last investment: Sep 2024
- Lead investor: 0%
- Last updated: Oct 2026
- LinkedIn: https://www.linkedin.com/in/naheedkurji/?ppe=1
- X (Twitter): https://twitter.com/NaheedKurji

Naheed Kurji is a seed investor in Toronto focused on Biotechnology and Medical. Naheed Kurji is the President and CEO of Cyclica, a Toronto-based biotechnology company that leverages artificial intelligence and computational biophysics to reshape the drug discovery process. Cyclica provides the pharmaceutical industry with an integrated, holistic, and end-to-end enabling platform that enhances how scientists design, screen,and personalize medicines for patients, and has recently been named by Deep Knowledge Analytics as one of the top 20 AI in Pharma companies globally. Naheed is passionate about how people interact with technology to make more informed and faster decisions, and is dedicated to advancing the responsible application of AI to healthcare problems. At Cyclica, he focuses on strategy and corporate development activities to affect change in the pharmaceutical industry, and strives to foster an environment where his team can solve the biggest challenges in human health through groundbreaking innovation. Naheed is a co-founder of The Alliance for Artificial Intelligence in Healthcare (AAIH), of which Naheed is 1 of 4 appointed Executive Officers. Naheed is an experienced professional specialized in strategic planning, corporate finance and entrepreneurship, having received an MBA from the University of Toronto, Rotman School of Management, and a Certificate from MIT on Artificial Intelligence and the Implication on Business Strategy. He has been featured in the Globe and Mail, CBC, Forbes, Vanity Fair, StartUp Health Magazine, WuXi Insider Perspective, and VentureBeat. Naheed is also a guest lecturer at various universities globally on the topic of entrepreneurship and AI in medicine.

## Contacts

5 contacts available for Naheed Kurji: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/naheed-kurji?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Medical | 1 | 50% |
| Health Care | 1 | 50% |
| Life Science | 1 | 50% |
| Pharmaceutical | 1 | 50% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Series B | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Canada | 1 | 50% |
| United Kingdom | 1 | 50% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| CardiaTec Biosciences | CardiaTec is a TechBio business that uses computational tools to unravel the biology underlying cardiovascular illness. CardiaTec uses massive and high-dimensional human omics data to better understand complicated disease biology and identify novel and differentiated therapies. | $6.5M | Seed | Sep 10, 2024 | https://www.cardiatec.ai/ |
| Cyclica | Cyclica is the partner of choice for data-driven drug discovery. The software developed by the company uses biophysics and artificial intelligence (AI) to improve drug discovery practices by generating a list of putative ligand-protein interactions, allowing health institutions to prioritize lead candidates, elucidate adverse effects, andunderstand repurposing opportunities. | $16.9M | Series B | Jun 24, 2020 | http://www.cyclicarx.com |

2 of 2 investments shown.

## Co-investors
- [APEX Ventures](https://shizune.co/investors/profile/apex-ventures-12df) — VC Fund, 1 deal together
- [APEX Ventures](https://shizune.co/investors/profile/apex-ventures-2) — VC Fund, 1 deal together
- [Chiesi Pharmaceuticals](https://shizune.co/investors/profile/chiesi-pharmaceuticals) — VC Fund, 1 deal together
- [Continuum Health Ventures](https://shizune.co/investors/profile/continuum-health-ventures) — VC Fund, 1 deal together
- [Drive Capital](https://shizune.co/investors/profile/drive-capital) — VC Fund, 1 deal together
- [GreenSky Ventures](https://shizune.co/investors/profile/greensky-capital) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund

### Similar country
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [Hiventures](https://shizune.co/investors/profile/hiventures) — VC Fund

## Featured in investor lists
- [Life Science Angel Investors in United Kingdom](https://shizune.co/investors/life-science-angel-investors-united-kingdom)
- [Life Science Angel Investors in Europe](https://shizune.co/investors/life-science-angel-investors-europe)

## FAQ

### What does Naheed Kurji invest in?

Naheed Kurji invests primarily in Biotechnology, Medical and Health Care startups, most often at Seed and Series B stage. Most of the 2 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Naheed Kurji?

Public channels for Naheed Kurji include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Naheed Kurji last invest?

The most recent investment recorded for Naheed Kurji closed in Sep 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co